Tamiflu use extended

The lower age limit for use of Tamiflu (oseltamivir) has been reduced from one year to six months of age when treating flu during a pandemic. Prophylactic use of the drug is not recommended under one year. The capsule SPCs now also provide instructions for preparing extemporaneous oral 10mg/ml or 15mg/ml solutions from capsules when the powder for oral suspension is unavailable.

View Tamiflu drug record

Further information: Roche


To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Statin prescribing 'commonly breaching NICE guidance'

Statin prescribing 'commonly breaching NICE guidance'

Prescribing of suboptimal statin regimens is 'extremely...

New contraindication for co-cyprindiol

New contraindication for co-cyprindiol

Cyproterone-containing medicines are now contraindicated...

GPs demand clarity on flu vaccination plans for 2020/21

GPs demand clarity on flu vaccination plans for 2020/21

GPs say they are struggling to plan flu vaccine orders...